These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20303323)

  • 1. Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study.
    Freiesleben Nl; Rosendahl M; Johannsen TH; Løssl K; Loft A; Bangsbøll S; Friis-Hansen L; Pinborg A; Andersen AN
    Reprod Biomed Online; 2010 May; 20(5):582-7. PubMed ID: 20303323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual cycle length in relation to antimüllerian hormone and follicle-stimulating hormone.
    Rashidi BH; Abediasl Z; Tehraninejad ES; Shariat M; Mahdavi A
    J Reprod Med; 2009 May; 54(5):315-8. PubMed ID: 19517697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.
    Isaza V; Requena A; García-Velasco JA; Remohí J; Pellicer A; Simón C
    J Reprod Med; 2003 Feb; 48(2):112-8. PubMed ID: 12621795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.
    Nelson SM; Yates RW; Fleming R
    Hum Reprod; 2007 Sep; 22(9):2414-21. PubMed ID: 17636277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.
    Lekamge DN; Lane M; Gilchrist RB; Tremellen KP
    J Assist Reprod Genet; 2008; 25(11-12):515-21. PubMed ID: 18972201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women.
    Tsepelidis S; Devreker F; Demeestere I; Flahaut A; Gervy Ch; Englert Y
    Hum Reprod; 2007 Jul; 22(7):1837-40. PubMed ID: 17485437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
    Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
    Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.
    Nelson SM; Yates RW; Lyall H; Jamieson M; Traynor I; Gaudoin M; Mitchell P; Ambrose P; Fleming R
    Hum Reprod; 2009 Apr; 24(4):867-75. PubMed ID: 19136673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination.
    Moro F; Tropea A; Scarinci E; Leoncini E; Boccia S; Federico A; Alesiani O; Lanzone A; Apa R
    Int J Gynaecol Obstet; 2016 Apr; 133(1):64-8. PubMed ID: 26873125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.